The decision may have been made to avoid regulation by the FDA, according to BuzzFeed.
"Advanced biotracking sensors would have made the Apple Watch less of a multipurpose consumer device and more of a medical device used to diagnose diseases or track chronic conditions — which could have opened the watch up to regulation by the U.S. Food and Drug Administration.
'I don’t think Apple wants to be a health-monitoring device maker,' said Harry Wang, director of health and mobile product research at Parks Associates. 'They do want to leverage their popularity on the iPhone as a device platform, integrating all health data that can be collected for different devices.'"
From the article "The Apple Watch Is Scaling Back Its Health Features" by Ian Servantes.
The latest entry in our 2025 Security Industry Predictions series is Elizabeth Parks, president and chief marketing officer at Parks Associates, which produces research about what’s going on in the ph...
Consumer technology research firm Parks Associates is launching its new Strategic Consulting Unit, a new initiative designed to help companies refine their strategies and product and service offerings...
Parks Associates’ Home Services Dashboard, an ongoing research project analyzing consumer surveys of 8,000 US Internet households, reveals ARPU for traditional services bundled with home Internet incr...
Parks Associates estimates $13 billion in annual revenues for professional monitoring of residential security systems and video devices by 2025. Going forward, we project the strongest growth for prof...
